RHUMBLINE ADVISERS - INOTEK PHARMACEUTICALS CORP ownership

INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102. A total of 66 filers reported holding INOTEK PHARMACEUTICALS CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 1.7%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of INOTEK PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2017$60,000
-45.0%
29,825
+67.3%
0.00%
Q4 2016$109,000
-40.8%
17,824
-8.2%
0.00%
-100.0%
Q3 2016$184,000
+37.3%
19,406
+7.8%
0.00%
Q2 2016$134,00018,0060.00%
Other shareholders

There were no reported owners of INOTEK PHARMACEUTICALS CORP in Q2 2016.

NameSharesValueWeighting ↓
View complete list of INOTEK PHARMACEUTICALS CORP shareholders